Arformoterol/Budesonide for COVID-19
NCT05055414
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
140
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronavirus Infection
Interventions
DRUG:
UI030
Sponsor
Korea United Pharm. Inc.